We are live on
!
Find out more
Brown Advisory Portfolio holdings
AUM
$60.9B
1-Year Est. Return
15.24%
This Fund
S&P 500
This Quarter
Est. Return
+9.9%
1 Year Est. Return
+15.24%
3 Year Est. Return
+71.23%
5 Year Est. Return
+86.65%
10 Year Est. Return
+447.92%
AUM
$30.8B
AUM Growth
+$2.83B
(+10%)
Cap. Flow
+$314M
Cap. Flow
% of AUM
1.02%
Top 10 Holdings %
Top 10 Hldgs %
29.43%
Holding
995
New
101
Increased
392
Reduced
278
Closed
51
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$434M |
| 2 |
Estee Lauder
EL
|
+$90.8M |
| 3 |
Visa
V
|
+$90M |
| 4 |
Amphenol
APH
|
+$67.6M |
| 5 |
ESRX
Express Scripts Holding Company
ESRX
|
+$57.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Idexx Laboratories
IDXX
|
+$409M |
| 2 |
CTXS
Citrix Systems Inc
CTXS
|
+$322M |
| 3 |
Apple
AAPL
|
+$115M |
| 4 |
TotalEnergies
TTE
|
+$31.5M |
| 5 |
Deckers Outdoor
DECK
|
+$27.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.08% |
| 2 | Healthcare | 15.56% |
| 3 | Financials | 11.89% |
| 4 | Industrials | 9.57% |
| 5 | Energy | 9.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Alphabet (Google) Class C
GOOG
$4.22T
| $1.14B | 3.69% |
40,770,527
-86,564
| -0.2% | -$2.19M |
|
|
2
Apple
AAPL
$4.81T
| $1.04B | 3.36% |
51,677,024
-6,082,524
| -11% | -$115M |
|
|
3
Visa
V
$677B
| $1.02B | 3.32% |
18,387,656
+1,784,384
| +11% | +$90M |
|
|
ESRX
4
DELISTED
Express Scripts Holding Company
ESRX
| $962M | 3.12% |
13,694,004
+876,059
| +7% | +$57.2M |
|
5
Qualcomm
QCOM
$183B
| $957M | 3.1% |
12,889,678
+174,135
| +1% | +$12.3M |
|
|
SCHW
6
Charles Schwab
SCHW
$174B
| $850M | 2.76% |
32,689,163
+382,253
| +1% | +$9.12M |
|
7
Fluor
FLR
$7.18B
| $825M | 2.67% |
10,273,108
-49,702
| -0.5% | -$3.8M |
|
8
SLB Ltd
SLB
$69.7B
| $824M | 2.67% |
9,148,918
+543,093
| +6% | +$49M |
|
9
Danaher
DHR
$127B
| $754M | 2.45% |
14,539,652
+67,402
| +0.5% | +$3.31M |
|
10
Starbucks
SBUX
$119B
| $707M | 2.29% |
18,039,878
-535,404
| -3% | -$21.2M |
|
|
MJN
11
DELISTED
Mead Johnson Nutrition Company
MJN
| $668M | 2.16% |
7,969,204
+515,789
| +7% | +$42M |
|
12
Intuitive Surgical
ISRG
$124B
| $665M | 2.16% |
15,576,930
+1,342,287
| +9% | +$56.5M |
|
|
13
Estee Lauder
EL
$30.3B
| $654M | 2.12% |
8,681,529
+1,253,411
| +17% | +$90.8M |
|
14
Core Laboratories
CLB
$516M
| $609M | 1.98% |
3,191,802
+23,071
| +0.7% | +$4.29M |
|
15
Accenture
ACN
$86.2B
| $603M | 1.95% |
7,332,088
+24,687
| +0.3% | +$1.87M |
|
|
WFM
16
DELISTED
Whole Foods Market Inc
WFM
| $601M | 1.95% |
10,390,234
+648,134
| +7% | +$38.4M |
|
|
SRCL
17
DELISTED
Stericycle Inc
SRCL
| $591M | 1.92% |
5,085,570
+52,875
| +1% | +$6.16M |
|
18
Ecolab
ECL
$75.6B
| $588M | 1.91% |
5,640,099
+32,826
| +0.6% | +$3.41M |
|
|
19
Amphenol
APH
$194B
| $581M | 1.89% |
52,144,928
+6,541,784
| +14% | +$67.6M |
|
20
Roper Technologies
ROP
$35.4B
| $558M | 1.81% |
4,022,789
+25,307
| +0.6% | +$3.29M |
|
21
TechnipFMC
FTI
$29.8B
| $526M | 1.71% |
13,548,536
+166,312
| +1% | +$6.46M |
|
22
Salesforce
CRM
$139B
| $524M | 1.7% |
9,494,546
+73,899
| +0.8% | +$3.95M |
|
23
Costco
COST
$412B
| $521M | 1.69% |
4,380,838
+355,329
| +9% | +$42.5M |
|
24
DaVita
DVA
$15B
| $514M | 1.67% |
8,117,830
+44,756
| +0.6% | +$2.63M |
|
|
CVD
25
DELISTED
COVANCE INC.
CVD
| $502M | 1.63% |
5,697,392
+17,005
| +0.3% | +$1.47M |
|
Similar funds
QCM
Brown Advisory's Q4 2013 Portfolio in Review
As of Q4 2013, Brown Advisory held 995 positions worth $30.8B, up 10% from $28B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Brown Advisory's Q4 2013 filing shows 101 new, 392 increased, 278 reduced and 51 closed positions. Its largest new stake was Plains GP Holdings: 157,910 shares worth $11.3M. The largest sale was Idexx Laboratories, an estimated $409M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 26% a quarter earlier, followed by Healthcare and Financials.
- Brown Advisory's largest Q4 2013 buy was Plains GP Holdings: 157,910 shares worth $11.3M.
- Brown Advisory added most to Gilead Sciences in Q4 2013, an estimated $434M increase.
- Brown Advisory's biggest Q4 2013 reduction was Idexx Laboratories, cutting an estimated $409M.
- Brown Advisory fully exited Ariad Pharmaceuticals Inc in Q4 2013, selling an estimated $19.5M.
- Brown Advisory's ten largest holdings make up 29% of its $30.8B portfolio in Q4 2013.
- Brown Advisory opened 101 new positions and closed 51 in Q4 2013.
- Brown Advisory's portfolio value rose 10% quarter-over-quarter to $30.8B.
Based on Brown Advisory's 13F filing for Q4 2013, filed 11 Feb 2014.